This material is extracted from a non-biological, natural source.
04238
Hydroxyapatite
puriss., meets analytical specification of Ph. Eur., BP, FCC, E341, ≥90% (calculated on glowed substance)
Sinonimo/i:
Calcium phosphate hydroxide, Durapatite, Hydroxylapatite
Autenticati per visualizzare i prezzi organizzativi e contrattuali.
Scegli un formato
1 KG
61,96 €
61,96 €
Prezzo di listino72,90 €Risparmia il 15%Disponibile per la spedizione OGGIDettagli
Informazioni su questo articolo
Formula condensata:
3Ca3(PO4)2 · Ca(OH)2
Numero CAS:
Peso molecolare:
502.31
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
41116107
EC Number:
215-145-7
MDL number:
Vai a
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutartiNome del prodotto
Hydroxyapatite, puriss., meets analytical specification of Ph. Eur., BP, FCC, E341, ≥90% (calculated on glowed substance)
InChI key
XYJRXVWERLGGKC-UHFFFAOYSA-D
InChI
1S/5Ca.3H3O4P.H2O/c;;;;;3*1-5(2,3)4;/h;;;;;3*(H3,1,2,3,4);1H2/q5*+2;;;;/p-10
SMILES string
[Ca++].[Ca++].[Ca++].[Ca++].O[Ca+].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O
grade
puriss.
assay
≥90% (calculated on glowed substance)
form
powder
quality
meets analytical specification of Ph. Eur., BP, FCC, E341
composition
Ca, 35-40%
impurities
residual solvents, complies
≤0.001% heavy metals (as Pb)
≤0.2% insoluble in HCl
loss
≤8% loss on ignition, 800 °C
anion traces
chloride (Cl-): ≤1500 mg/kg
fluoride (F-): ≤50 mg/kg
sulfate (SO42-): ≤5000 mg/kg
cation traces
As: ≤2 mg/kg
Cd: ≤1 mg/kg
Cu: ≤20 mg/kg
Fe: ≤400 mg/kg
Hg: ≤1 mg/kg
Pb: ≤2 mg/kg
Zn: ≤20 mg/kg
Quality Level
Cerchi prodotti simili? Visita Guida al confronto tra prodotti
1 of 4
Questo articolo | 21223 | 900203 | 391947 |
|---|---|---|---|
| form powder | form powder | form powder | form solid |
| Quality Level 200 | Quality Level 100 | Quality Level 100 | Quality Level 100 |
| grade puriss. | grade purum p.a. | grade - | grade - |
| assay ≥90% (calculated on glowed substance) | assay ≥90% (as Ca3(PO4)2, KT) | assay - | assay - |
| quality meets analytical specification of Ph. Eur., BP, FCC, E341 | quality - | quality - | quality - |
| composition Ca, 35-40% | composition - | composition - | composition - |
Application
- New Physico-Chemical Analysis of Magnesium-Doped Hydroxyapatite in Dextran Matrix Nanocomposites.: This research article focuses on the development and characterization of magnesium-doped hydroxyapatite within a dextran matrix, emphasizing its potential applications in biomedical and tissue engineering fields (Predoi et al., 2023).
Classe di stoccaggio
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)
Scegli una delle versioni più recenti:
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
Mechanical properties of sintered hydroxyapatite for prosthetic applications.
Akao M ,et al.
J. Mater. Sci., 16(3), 809-812 (1981)
Chemical characterization of silicon-substituted hydroxyapatite
Gibson I, et al.
Journal of Biomedical Materials Research, 44(4), 422-428 (1999)
P Ducheyne et al.
Biomaterials, 7(2), 97-103 (1986-03-01)
Hydroxyapatite from two sources was electrophoretically deposited onto flat titanium plate material. Depending upon the deposition conditions various changes in the structure of the ceramic were identified. A well-adhering Ti-P compound was present at the interface. Hydroxyapatite oxygenated to various
Bjarke Viberg et al.
Acta orthopaedica, 84(3), 254-259 (2013-04-19)
Elderly patients with displaced femoral neck fractures are commonly treated with a hemiarthroplasty (HA), but little is known about the long-term failure of this treatment. We compared reoperation rates for patients aged at least 75 years with displaced femoral neck
Sophie E P New et al.
Circulation research, 113(1), 72-77 (2013-04-26)
We previously showed that early calcification of atherosclerotic plaques associates with macrophage accumulation. Chronic renal disease and mineral imbalance accelerate calcification and the subsequent release of matrix vesicles (MVs), precursors of microcalcification. We tested the hypothesis that macrophage-derived MVs contribute
-
Are the hydroxyapatite (product no. 0438 Lot no 92170) synthesis or obtained from naturall sources?
1 risposta-
Utile?
-
-
What is the particle size of this product?
1 risposta-
The particle size for this product is not determined. However, other hydroxyapatite products may be of interest as the particle size is available:
900203; Hydroxyapatite, powder, 10 μm, spec. surface area ≥80 m2/g
https://www.sigmaaldrich.com/certificates/sapfs/PROD/sap/certificate_pdfs/COFA/Q14/900203-BULKMKCT5305.pdf900204; Hydroxyapatite, powder, 5 μm, surface area ≥80 m2/g
https://www.sigmaaldrich.com/certificates/sapfs/PROD/sap/certificate_pdfs/COFA/Q14/900204-BULKMKCT6258.pdfUtile?
-
Filtri attivi
Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..
Contatta l'Assistenza Tecnica